Your browser doesn't support javascript.
loading
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
Weiss, Brian D; Yanik, Gregory; Naranjo, Arlene; Zhang, Fan F; Fitzgerald, Wendy; Shulkin, Barry L; Parisi, Marguerite T; Russell, Heidi; Grupp, Stephan; Pater, Luke; Mattei, Peter; Mosse, Yael; Lai, Hollie A; Jarzembowski, Jason A; Shimada, Hiroyuki; Villablanca, Judith G; Giller, Roger; Bagatell, Rochelle; Park, Julie R; Matthay, Katherine K.
Afiliación
  • Weiss BD; Cincinnati Children's Hospital, University of Cincinnati School of Medicine Cincinnati, Ohio.
  • Yanik G; CS Mott Children's Hospital, University of Michigan School of Medicine, Ann Arbor, Michigan.
  • Naranjo A; Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida.
  • Zhang FF; Children's Oncology Group Statistics and Data Center, Monrovia, California.
  • Fitzgerald W; Children's National Health System, District of Columbia, Washington.
  • Shulkin BL; St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Parisi MT; Seattle Children's Hospital, Seattle, Washington.
  • Russell H; Texas Children's Cancer and Hematology Centers, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas.
  • Grupp S; Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Pater L; Cincinnati Children's Hospital, University of Cincinnati School of Medicine Cincinnati, Ohio.
  • Mattei P; Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Mosse Y; Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lai HA; Children's Hospital of Orange County, Orange, California.
  • Jarzembowski JA; Midwest Children's Cancer Center, Milwaukee, Wisconsin.
  • Shimada H; Lucille Packards Children's Hospital, Palo Alto, California.
  • Villablanca JG; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Giller R; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
  • Bagatell R; Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Park JR; Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington.
  • Matthay KK; UCSF Benioff Children's Hospital, University of California San Francisco School of Medicine, San Francisco, California.
Pediatr Blood Cancer ; 68(10): e29117, 2021 10.
Article en En | MEDLINE | ID: mdl-34028986
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: 3-Yodobencilguanidina / Neuroblastoma Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: 3-Yodobencilguanidina / Neuroblastoma Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article